Found: 81
Select item for more details and to access through your institution.
The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1178, doi. 10.1111/bjh.19273
- By:
- Publication type:
- Article
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1271, doi. 10.1111/bjh.19194
- By:
- Publication type:
- Article
Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib – Case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 86, doi. 10.1111/bjh.19064
- By:
- Publication type:
- Article
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 108, doi. 10.1111/bjh.19131
- By:
- Publication type:
- Article
Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519
- By:
- Publication type:
- Article
Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 48, doi. 10.1111/bjh.18738
- By:
- Publication type:
- Article
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 515, doi. 10.1016/j.clml.2023.03.010
- By:
- Publication type:
- Article
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients.
- Published in:
- Transfusion Medicine, 2023, v. 33, n. 3, p. 254, doi. 10.1111/tme.12952
- By:
- Publication type:
- Article
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2596, doi. 10.3390/cancers15092596
- By:
- Publication type:
- Article
How I manage mantle cell lymphoma: indolent versus aggressive disease.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 185, doi. 10.1111/bjh.18697
- By:
- Publication type:
- Article
Venetoclax induces deep and durable minimal residual disease‐negative remission in high‐risk TP53 disrupted B prolymphocytic leukaemia.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 590, doi. 10.1111/ejh.13837
- By:
- Publication type:
- Article
Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46–62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory disease
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 40, doi. 10.1111/bjh.18378
- By:
- Publication type:
- Article
Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 431, doi. 10.1111/bjh.18104
- By:
- Publication type:
- Article
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: updated results from the phase 1/2 BRUIN study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
- By:
- Publication type:
- Article
Pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: updated results from the phase 1/2 BRUIN study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
- By:
- Publication type:
- Article
Guideline for the treatment of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 5, p. 544, doi. 10.1111/bjh.18075
- By:
- Publication type:
- Article
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.888109
- By:
- Publication type:
- Article
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 129, doi. 10.1002/hon.2943
- By:
- Publication type:
- Article
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 864, doi. 10.1111/bjh.17882
- By:
- Publication type:
- Article
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262388
- By:
- Publication type:
- Article
Reduction in incidence of non‐COVID‐19 respiratory virus infection amongst haematology inpatients following UK social distancing measures.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 194, doi. 10.1111/bjh.17651
- By:
- Publication type:
- Article
Oral Abstract: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01273-8
- By:
- Publication type:
- Article
Poster: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01392-6
- By:
- Publication type:
- Article
CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S315, doi. 10.1016/S2152-2650(21)01746-8
- By:
- Publication type:
- Article
Interpretation of retrospective data evaluating high‐dose methotrexate as central nervous system prophylaxis in diffuse large B‐cell lymphoma; caution required.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E338, doi. 10.1002/ajh.26257
- By:
- Publication type:
- Article
The use of frailty assessments in treating older adults with aggressive lymphomas.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 4, p. 677, doi. 10.1111/bjh.17384
- By:
- Publication type:
- Article
Limited‐stage diffuse large B‐cell lymphoma: current management and challenges.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 508, doi. 10.1111/bjh.17359
- By:
- Publication type:
- Article
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO‐idel).
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 69, doi. 10.1111/bjh.17475
- By:
- Publication type:
- Article
Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 727, doi. 10.1111/bjh.17421
- By:
- Publication type:
- Article
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 290, doi. 10.1111/bjh.17363
- By:
- Publication type:
- Article
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 563, doi. 10.1111/ejh.13588
- By:
- Publication type:
- Article
Acquired platelet dysfunction in newly diagnosed myeloma.
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 17, doi. 10.1002/jha2.152
- By:
- Publication type:
- Article
Development of a Conceptual Model of Chronic Lymphocytic Leukemia to Better Understand the Patient Experience.
- Published in:
- Patient, 2021, v. 14, n. 1, p. 75, doi. 10.1007/s40271-020-00440-9
- By:
- Publication type:
- Article
The investigation and management of follicular lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 363, doi. 10.1111/bjh.16872
- By:
- Publication type:
- Article
Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 667, doi. 10.1111/ejh.13486
- By:
- Publication type:
- Article
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 4, p. 476, doi. 10.1111/ejh.13469
- By:
- Publication type:
- Article
Prognostication in Richter syndrome: context is everything.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 811, doi. 10.1111/bjh.16757
- By:
- Publication type:
- Article
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 394, doi. 10.1111/bjh.16592
- By:
- Publication type:
- Article
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 231, doi. 10.1111/ejh.13422
- By:
- Publication type:
- Article
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 879, doi. 10.1111/bjh.16451
- By:
- Publication type:
- Article
Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 684, doi. 10.1111/bjh.16416
- By:
- Publication type:
- Article
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
- By:
- Publication type:
- Article
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229469
- By:
- Publication type:
- Article
Another disappointment in treating relapsed, refractory high‐risk aggressive B‐cell lymphomas.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 2, p. 202, doi. 10.1111/bjh.16259
- By:
- Publication type:
- Article
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. 185, doi. 10.1111/bjh.16070
- By:
- Publication type:
- Article
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of R‐GCVP in patients with late relapse of diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e191, doi. 10.1111/bjh.16071
- By:
- Publication type:
- Article
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. e94, doi. 10.1111/bjh.15927
- By:
- Publication type:
- Article